Abnormalities in the Von Willebrand-Angiopoietin Axis Contribute to Dysregulated Angiogenesis and Angiodysplasia in Children With a Glenn Circulation
- PMID: 33778210
- PMCID: PMC7987544
- DOI: 10.1016/j.jacbts.2020.12.014
Abnormalities in the Von Willebrand-Angiopoietin Axis Contribute to Dysregulated Angiogenesis and Angiodysplasia in Children With a Glenn Circulation
Abstract
Children with a bidirectional superior cavopulmonary (Glenn) circulation develop angiodysplasia and pulmonary arteriovenous malformations (AVMs). The von Willebrand factor (vWF)-angiopoietin axis plays a major role in AVM formation in multiple diseases. We observed derangements in global angiogenic signaling, vWF metabolism, angiopoietins, and in vitro angiogenesis in children with a Glenn circulation versus controls and within Glenn pulmonary versus systemic circulations. These findings support the novel hypothesis that abnormalities in the vWF-angiopoietin axis may dysregulate angiogenesis and contribute to Glenn pulmonary AVMs. The vWF-angiopoietin axis may be a target to correct angiogenic imbalance in Glenn patients, for whom no targeted therapy exists.
Keywords: ADAMTS-13, a disintegrin and metalloproteinase thrombospondin (motif) #13; AVM, arteriovenous malformation; EBM, endothelial basal media; EGM, endothelial growth media; Glenn; HUVEC, human umbilical vein endothelial cell; IVC, inferior vena cava; LVAD, left ventricular assist device; PA, pulmonary artery; SVC, superior vena cava; angiogenesis; angiopoietin; arteriovenous malformation; vWF, von Willebrand factor; von Willebrand factor.
© 2021 The Authors.
Conflict of interest statement
This project was performed with support from the Big Hearts to Little Hearts Foundation and the Congenital Heart Disease Coalition. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures






Comment in
-
Pulmonary Arteriovenous Malformations and the Hepatic "Black Box": Are We Emerging From the Darkness?JACC Basic Transl Sci. 2021 Mar 22;6(3):236-238. doi: 10.1016/j.jacbts.2021.02.004. eCollection 2021 Mar. JACC Basic Transl Sci. 2021. PMID: 33779631 Free PMC article.
-
JACC: Basic to Translational Science 2021 Thomas Force Young Investigator Award Winner.JACC Basic Transl Sci. 2022 Apr 25;7(4):422-424. doi: 10.1016/j.jacbts.2022.02.001. eCollection 2022 Apr. JACC Basic Transl Sci. 2022. PMID: 35540103 Free PMC article. No abstract available.
Similar articles
-
Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.Circ Heart Fail. 2018 Sep;11(9):e004638. doi: 10.1161/CIRCHEARTFAILURE.117.004638. Circ Heart Fail. 2018. PMID: 30354363
-
Pulmonary artery endothelial cell phenotypic alterations in a large animal model of pulmonary arteriovenous malformations after the Glenn shunt.Ann Thorac Surg. 2013 Oct;96(4):1442-1449. doi: 10.1016/j.athoracsur.2013.05.075. Epub 2013 Aug 20. Ann Thorac Surg. 2013. PMID: 23968766 Free PMC article.
-
Von Willebrand factor, angiodysplasia and angiogenesis.Mediterr J Hematol Infect Dis. 2013 Sep 2;5(1):e2013060. doi: 10.4084/MJHID.2013.060. Mediterr J Hematol Infect Dis. 2013. PMID: 24106610 Free PMC article. Review.
-
Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.JACC Heart Fail. 2015 Nov;3(11):860-9. doi: 10.1016/j.jchf.2015.06.016. Epub 2015 Oct 7. JACC Heart Fail. 2015. PMID: 26454844
-
Acquired von Willebrand syndrome associated with left ventricular assist device.Blood. 2016 Jun 23;127(25):3133-41. doi: 10.1182/blood-2015-10-636480. Epub 2016 May 3. Blood. 2016. PMID: 27143258 Free PMC article. Review.
Cited by
-
Pulmonary Arteriovenous Malformations and the Hepatic "Black Box": Are We Emerging From the Darkness?JACC Basic Transl Sci. 2021 Mar 22;6(3):236-238. doi: 10.1016/j.jacbts.2021.02.004. eCollection 2021 Mar. JACC Basic Transl Sci. 2021. PMID: 33779631 Free PMC article.
-
Hepatic factor may not originate from hepatocytes.Front Cardiovasc Med. 2022 Sep 6;9:999315. doi: 10.3389/fcvm.2022.999315. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36148055 Free PMC article.
-
Pulmonary Vascular Sequelae of Palliated Single Ventricle Circulation: Arteriovenous Malformations and Aortopulmonary Collaterals.J Cardiovasc Dev Dis. 2022 Sep 17;9(9):309. doi: 10.3390/jcdd9090309. J Cardiovasc Dev Dis. 2022. PMID: 36135454 Free PMC article. Review.
-
sVEGFR1 Is Enriched in Hepatic Vein Blood-Evidence for a Provisional Hepatic Factor Candidate?Front Pediatr. 2021 Jun 14;9:679572. doi: 10.3389/fped.2021.679572. eCollection 2021. Front Pediatr. 2021. PMID: 34195162 Free PMC article.
-
Impact of hepatopulmonary syndrome in liver transplantation candidates and the role of angiogenesis.Eur Respir J. 2022 Aug 4;60(2):2102304. doi: 10.1183/13993003.02304-2021. Print 2022 Aug. Eur Respir J. 2022. PMID: 34949701 Free PMC article.
References
-
- Starnes S.L., Duncan B.W., Kneebone J.M. Pulmonary microvessel density is a marker of angiogenesis in children after cavopulmonary anastomosis. J Thorac Cardiovasc Surg. 2000;120:902–907. - PubMed
-
- Starnes S.L., Duncan B.W., Fraga C.H. Rat model of pulmonary arteriovenous malformations after right superior cavopulmonary anastomosis. Am J Physiol Heart Circ Physiol. 2002;283:H2151–H2156. - PubMed
-
- Srivastava D., Preminger T., Lock J.E. Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart disease. Circulation. 1995;92:1217–1222. - PubMed
-
- Kopf G.S., Laks H., Stansel H.C., Hellenbrand W.E., Kleinman C.S., Talner N.S. Thirty-year follow-up of superior vena cava-pulmonary artery (Glenn) shunts. J Thorac Cardiovasc Surg. 1990;100:662–670. discussion 670–1. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous